Donohue Cara, Carnaby Giselle, Reilly Mary Catherine, Colquhoun Ryan J, Lacomis David, Garand Kendrea L Focht
Department of Communication Science and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
eNeurologicalSci. 2023 Feb 21;31:100452. doi: 10.1016/j.ensci.2023.100452. eCollection 2023 Jun.
To systematically evaluate post-exercise outcomes related to function and quality of life in people with ALS.
PRISMA guidelines were used for identifying and extracting articles. Levels of evidence and quality of articles were judged based on and the Outcomes were analyzed with Comprehensive Meta-Analysis V2 software, random effects models, and Hedge's G. Effects were examined at 0-4 months, up to 6 months, and > 6 months. Pre-specified sensitivity analyses were performed for 1) controlled trials vs. all studies and 2) ALSFRS-R bulbar, respiratory, and motor subscales. Heterogeneity of pooled outcomes was computed with the I statistic.
16 studies and seven functional outcomes met inclusion for the meta-analysis. Of the outcomes explored, the ALSFRS-R demonstrated a favorable summary effect size and had acceptable heterogeneity and dispersion. While FIM scores demonstrated a favorable summary effect size, heterogeneity limited interpretations. Other outcomes did not demonstrate a favorable summary effect size and/or could not be reported due to few studies reporting outcomes.
This study provides inconclusive guidance regarding exercise regimens to maintain function and quality of life in people with ALS due to study limitations (e.g., small sample size, high attrition rate, heterogeneity in methods and participants, etc.). Future research is warranted to determine optimal treatment regimens and dosage parameters in this patient population.
系统评估肌萎缩侧索硬化症(ALS)患者运动后与功能及生活质量相关的结果。
采用PRISMA指南来识别和提取文章。根据[具体标准1]和[具体标准2]判断文章的证据水平和质量。使用综合Meta分析V2软件、随机效应模型和Hedge's G对结果进行分析。在0至4个月、长达6个月以及超过6个月时检查效应。对1)对照试验与所有研究,以及2)ALSFRS-R延髓、呼吸和运动分量表进行预先设定的敏感性分析。用I统计量计算汇总结果的异质性。
16项研究和7个功能结果符合纳入荟萃分析的标准。在所探讨的结果中,ALSFRS-R显示出有利的汇总效应量,并且具有可接受的异质性和离散度。虽然FIM评分显示出有利的汇总效应量,但异质性限制了对结果的解释。其他结果未显示出有利的汇总效应量,和/或由于报告结果的研究较少而无法报告。
由于研究局限性(例如,样本量小、损耗率高、方法和参与者存在异质性等),本研究对于维持ALS患者功能和生活质量的运动方案提供了不确定的指导。有必要进行未来研究以确定该患者群体的最佳治疗方案和剂量参数。